Ocular Therapeutix, Inc. (OCUL) stock forecast and price target
Price $6.21 · data as of November 13, 2026
12-month price target
Average target$25.73
Upside / downside+314.3%
Analysts11
ConsensusStrong buy
Low $14.00Average $25.73High $34.00
Gold marker: average target · white marker: today’s price ($6.21)
Analyst ratings
Strong buy 4Buy 8Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.53 | −7.7% | $51M |
| Next fiscal year ends December 31, 2027 | $-1.59 | −4.2% | $91M |
| Quarter after ends March 31, 2027 | $-0.38 | +4.6% | $12M |
Consensus of the analysts covering Ocular Therapeutix, updated daily. In the last 30 days 3 estimates were raised and 0 lowered.
Frequently asked questions
What is the Ocular Therapeutix stock price target?
The average 12-month target from 11 analysts is $25.73, 314.3% above the current price of $6.21 Targets range from $14.00 to $34.00.
Is Ocular Therapeutix a buy according to analysts?
The consensus rating is “Strong buy” (4 strong buy, 8 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Ocular Therapeutix expected to earn?
Analysts expect EPS of $-1.53 for the fiscal year ending December 31, 2026 and $-1.59 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.